Wird geladen...

Phase II Randomized, Double-Blinded Comparison of A Single High Dose (5×10(8) TCID(50)) of Modified Vaccinia Ankara Compared To A Standard Dose (1×10(8) TCID(50)) in Healthy Vaccinia-Naïve Individuals

INTRODUCTION: Reintroduction of Variola major as an agent of bioterrorism remains a concern. Time to seroconversion and plaque reduction neutralizing antibody titers (PRNT) of 1 or 2 standard doses (SD) were compared to a single high dose (HD) of modified vaccinia Ankara (MVA). METHODS: Ninety subje...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Frey, Sharon E., Winokur, Patricia L., Hill, Heather, Goll, Johannes B., Chaplin, Paul, Belshe, Robert B.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	2014
Schlagworte:	Article
Online Zugang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4106233/ https://ncbi.nlm.nih.gov/pubmed/24607004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.02.043
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Phase II Randomized, Double-Blinded Comparison of A Single High Dose (5×10(8) TCID(50)) of Modified Vaccinia Ankara Compared To A Standard Dose (1×10(8) TCID(50)) in Healthy Vaccinia-Naïve Individuals

Ähnliche Einträge